Placental Stem Cell Therapy for Neurological Disorders Market Opportunities Emerging from Increasing Awareness and Adoption

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Placental Stem Cell Therapy for Neurological Disorders Market- (By Type (Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy), By End-User (Hospitals & Specialty Clinics, Clinics Research Organizations, Research Institutes & Academics)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Placental Stem Cell Therapy for Neurological Disorders Market is valued at US$ 384.09 Mn in 2022, and it is expected to reach US$ 2,049.44 Mn by 2031, with a CAGR of 20.6% during a forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2121

The placenta serves a critical function in supporting fetal development by facilitating the exchange of gases, nutrients, and the removal of waste during pregnancy. In recent years, the growing application of human amniotic/amnion epithelial cells (hAECs) in regenerative medicine has driven substantial investment in the placental stem cell therapy market for neurological disorders. Allogeneic hAECs have shown promising outcomes in clinical trials targeting conditions such as leukemia and bronchopulmonary dysplasia (BPD), particularly in developed regions where allogeneic stem cell transplantation procedures are increasingly performed, thereby fueling market growth.

The placenta's high cellular yield, coupled with its origin from an infection-free environment, minimizes the risk of disease transmission, serving as a key factor supporting the adoption of placental stem cell therapies. Moreover, ongoing advancements in cell-based therapeutic technologies have heightened interest in leveraging placental stem cells to address a range of conditions, including neurological disorders, lung and liver injuries, acute kidney failure, and cardiovascular diseases, thereby expanding the market's overall potential.

List of Prominent Players in the Placental Stem Cell Therapy for Neurological Disorders Market:
• Mesoblast Ltd.
• Pleurite Therapeutic
• Remeron Group
• AthersysInc
• Cordlife India
• Life Cell International Pvt. Ltd
• Cryo-Cell International Inc.
• CBR Systems
• Cellularity Inc.
• Cynara
• Others

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics
Drivers:
The regenerative medicine sector is increasingly leveraged to repair and restore damaged cells, offering effective therapeutic solutions for a range of medical conditions. Numerous companies are conducting foundational research and preclinical studies to evaluate the potential of stem cells in regenerating tissues for the treatment of neurological disorders. Significant investments in cellular therapies for oncology are also expected to support market growth.

The global placental stem cell therapy market for neurological disorders is witnessing rapid expansion, driven by rising demand, increased industrialization, growing consumer awareness, technological advancements, and the continuous evolution of the healthcare sector. Revenue generation and sales within this market have demonstrated substantial growth, and these positive trends are anticipated to persist throughout the forecast period, reflecting the ongoing adoption of innovative regenerative therapies.

Challenges:
Market growth is constrained by the absence of standardized protocols and comprehensive guidelines for placental stem cell therapy, which can result in variability in treatment outcomes. Limited awareness among healthcare providers and patients regarding the therapeutic benefits and availability of placental stem cell therapies may also impede adoption. Ethical concerns related to tissue sourcing and informed consent present additional barriers. Furthermore, the high cost of placental stem cell therapy restricts accessibility, limiting its reach to a wider patient population.

Regional Trends:
North America is projected to maintain a leading share of the global placental stem cell therapy market for neurological disorders, driven by the presence of key industry players and strategic growth initiatives. The Asia-Pacific region holds the second-largest market share, supported by a robust healthcare infrastructure and ongoing investments in advanced medical technologies, which collectively contribute to the market's continued expansion.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2121

Recent Developments
• In Jan 2021, Celularity Inc. made an announcement regarding the release of the 100th cord blood stem cell unit by its Lifebank subsidiary. This unit will be utilised in an autologous cord blood transplant procedure, specifically aimed at treating an eight-year-old youngster who has been diagnosed with autism spectrum disorder.

Curious about this latest version of the report? Enquiry Before Buying:
Segmentation of Placental Stem Cell Therapy for Neurological Disorders Market-
By Type
• Allogeneic Placental Stem Cell Therapy
• Autologous Placental Stem Cell Therapy
By End-User
• Hospitals & Specialty Clinics
• Clinics Research Organizations
• Research Institutes & Academics
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/placental-stem-cell-therapy-for-neurological-disorders-market/2121

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.